Bio-Path Holdings's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Bio-Path Holdings (NASDAQ:BPTH) is scheduled to release its quarterly earnings report on March 8, 2024, with an estimated EPS of $-5.40. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows mixed reactions in stock price to past earnings performances, with the last quarter showing a 1.2% increase post-earnings. Currently, BPTH shares are trading at $6.44, marking a 77.36% decline over the past year, indicating a bearish sentiment among long-term shareholders.
March 07, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Bio-Path Holdings is expected to announce its quarterly earnings with an anticipated EPS of $-5.40. The focus will be on beating this estimate and the future guidance. The stock has seen a significant decline over the past year, indicating bearish sentiment.
The anticipation of Bio-Path Holdings' earnings report and its potential to beat the EPS estimate or provide positive future guidance could influence short-term stock movement. However, the significant yearly decline and mixed historical price reactions post-earnings suggest a cautious approach, leading to a neutral score.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100